Although asbestos continues to be a source of illness – and the litigation that results from it – there is seemingly no end to product liability.
By Levin Papantonio Attorney Daniel Nigh
I’ve spoken with a few prospective clients who have felt bad for DePuy and Johnson & Johnson. They thought that the corporations had good intentions with these recalled hips and just all of a sudden found out these hips were bad and immediately recalled them. However, that couldn’t be further from the truth. These major corporations put profit over the safety of the patients.
FDA Complaints Regarding the Recalled DePuy Hip (ASR) and All Metal on Metal Hips Continue to Mount Up
Berry Meier, of the New York Times, has reported yet another installment on the defective DePuy hips and on Metal on Metal hips in general.
In the first case of the so-called Engle progeny to reach the Florida Supreme Court, the court has declined to review a lower court’s decision upholding $3.3 million in compensatory damages and $25 million in punitive damages for the widow of a smoker. (R.J. Reynolds Tobacco Co. v. Martin, No. SC11-483 (Fla. July 19, 2011).)
By The News Service of Florida, Herald-Tribune
In a decision with huge implications for lawsuits against tobacco companies, the Florida Supreme Court on Tuesday declined to hear R.J. Reynolds’ appeal of a $28.3 million verdict in the death of a Panhandle smoker.
Court ruling may be big help for smoker plaintiffs
Legal / Law Matters
Jose Pagliery, Daily Business Review, On Thursday December 16, 2010, 3:02 am
The oil seems disappeared in the gulf of Mexico, now argues the lawyers about how many billions of dollars BP will pay to the victims of the environmental disaster.
Pensacola attorney Brian Barr is one of only four lawyers chosen by a federal judge to oversee thousands of claims against BP, Halliburton and Transocean for damages caused by the Gulf oil spill.
[Norman, Oklahoma] – Peter Mougey, a partner in the Pensacola-based law firm Levin Papantonio was, on Friday, October 15, inducted as the president of PIABA, the national securities bar. Mougey is the chair of the firm’s securities department.
[New York, N.Y., June 25, 2010] A jury in the United States District Court for the Southern District of New York found that Merck's osteoporosis drug Fosamax was defectively designed and unreasonably dangerous. As reported in the Wall St. Journal, the jury verdict raises serious questions about the safety of Fosamax for some patients. A medication widely prescribed for loss of bone density which might lead to osteoporosis, Fosamax has been linked not only to osteonecrosis of the jaw (a rotting of the jaw bone), but also more recently to serious fractures of the femur.
Release Date: 4/26/2004
Case Turns On What Constitutes Adequate Warning
By Correy E. Stephenson
In the latest Rezulin case to reach trial, a New York jury awarded $2 million to a woman who suffered side effects from the diabetes drug, but had no evidence of permanent liver damage.
With approximately 8,700 Rezulin lawsuits filed in state and federal courts across the country, the April trial was closely watched for indications of whether the mass tort is likely to be successful.
Source: Pensacola News Journal | Release Date: 4/6/2004
Settlement covers property, medical study in Agrico toxic case
Steve Mraz @ PensacolaNewsJournal.com
ConocoPhillips has agreed to a $70 million settlement with Pensacola residents whose property is potentially contaminated by a toxic plume that has spread from the old Agrico Chemical Co. fertilizer plant in central Pensacola to Bayou Texar.